Corcept Therapeutics Inc
CORT· Nasdaq
Released Nov 1, 2016, after the close
10-Q filed Nov 2, 2016, 33 days after period end · 0001564590-16-026776
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $21.73M | $13.26M | $7.28M | $2.63M |
| Net Income | $2.59M | -$601.00K | -$6.01M | -$10.91M |
| EPS Diluted | $0.02 |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.06 |
| -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.